Australia's largest stock trading and investment forum Australia's #1 stock forum

ACW

3.85%

2.7¢ actinogen medical limited

I think it is more of the past efficacy trials that were good...

First 44 Last

Share
Profile

Follow
carnabombers

4,375 Posts.

1267

10/10/22

14:07

Post #: 64119370
Share

Originally posted by fiveyearplan: ↑

"great results but the fact we called the nature of this announcement due to the trading before the stock went into trading halt is demoralizing.
insiders get a nice 24hr 40% scalp with long term ( and long suffering ) share holders have to ride the waves of public news and risks associated with being in the dark.
I wish governments did more about insider trading."

Easy conspiracy theory, but rather than playing the victim, reflect on the fact that ACW have been flagging this upcoming event literally for months.
If you had been paying attention to the calendar, you could have bought shares last week, on the basis it was October and the news event was getting closer.
Indeed, the ACW share price started rallying from late September, in anticipation.
Perhaps some investors were simply paying attention, rather than insider trading.
In a contest between conspiracy and incompetence to explain certain events, incompetence is usually the cause.

Expand

I think it is more of the past efficacy trials that were good but didn't test for bio markers. Also current md is next level compared to previous md. Comms along the way were good and positive so if you kept informed alongf the way, it was a good chance that these results would be positive. Nothing is guaranteed of course but the sum of the bits along the way were good.

ACW Price at posting: 12.3¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

What's causing the cost-of-living crisis, and how to navigate it

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk